Habenula volume increases with disease severity in unmedicated major depressive disorder as revealed by 7T MRI
The COMTp.Val158Met Polymorphism and Cognitive Performance in Adult Development, Healthy Aging and Mild Cognitive Impairment.
Dynamics of melanin-concentrating hormone (MCH) serum levels in major depressive disorder during antidepressant treatment
Onset of Depression Inventory"--comparison between the data of depressed patients and their relatives
Association of speed of onset and speed of recovery of depressive episodes in patients with major depression.
Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.
Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (-)-[(18)F]Flubatine in humans.
Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease.
Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years.
Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease.
Test-retest stability of the Onset of Depression Inventory.
Neuroborreliosis-associated cerebral vasculitis: long-term outcome and healthrelatedquality of life
Zerebrale Vaskulitis – ein Update
Weitere Publikationen von Prof. Dr. med. Tobias Back finden Sie hier